Why 29Metals, Cobram Estate, Ora Banda, and Telix Shares Are Rising Today

Why 29Metals, Cobram Estate, Ora Banda, and Telix shares are rising today

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a disappointing decline. At the time of writing, the benchmark index is down 0.6% to 8,794.8 points. Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising: 29Metals Ltd (ASX: 29M) The 29Metals share price is up 3.5% to 43.5 cents. This follows the release of results from Near Mine Exploration, Resource Extension, and Resour…

Telix and FDA Agree on Resubmission Pathway for TLX101-CDx (Pixclara®) U.S. NDA

Telix and FDA Agree on Resubmission Pathway for TLX101-CDx (Pixclara®) U.S. NDA Melbourne (Australia) and Indianapolis, IN (U.S) | 9 September 2025 Telix today announces that it has reached agreement with the United States (U.S.) Food and Drug Administration (FDA) regarding resubmission of its New Drug Application (NDA) for TLX101-CDx (Floretyrosine F18 or 18F-FET, Pixclara®[1]), an investigational agent for the imaging of glioma, a rare and l…

Telix (ASX: TLX) Gets FDA Green Light to Resubmit — What Investors Should Know

Telix Pharmaceuticals Gains FDA Clarity on Glioma Imaging Agent Telix Pharmaceuticals (ASX: TLX) has given investors reason to sit up and take notice. The company announced it has reached agreement with the U.S. Food and Drug Administration on the resubmission of its new drug application for TLX101-CDx (Pixclara), an imaging agent designed for glioma. What…